Table 1

Patient characteristics

 Discovery cohortValidation cohort
ControlCDUCControlCDUC
Patients, n (m/f)20 (10/10)15 (10/5)15 (7/8)19 (9/10)15 (10/5)15 (6/9)
Age, y*15.5 (11.6–16.6)13.9 (10.8–16.6)14.8 (13.3–16.3)15.3 (12.8–16.5)14.1 (10.8–15.6)13.7 (11.1–16.5)
PCDAI/PUCAI*NA37.5 (32.5–57.5)45.0 (30.0–70.0)NA47.5 (32.5–57.5)50.0 (40.0–70.0)
Classification
 A1a3 2
 A1b12 13
 L13 0
 L22 2
 L310 13
 L4a4 9
 L4b1 2
 B115 15
 B20 0
 P4 2
 G012 13
 G13 2
 E1 0 0
 E2 1 1
 E3 1 1
 E4 13 13
 S0 10 10
 S1 5 5
  • *Values shown as median (IQR).

  • CD, Crohn's disease; NA, not applicable; PCDAI, Pediatric Crohn's Disease Activity Index; PUCAI, Pediatric UC Activity Index.